Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry.

Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry.

Vitamin K antagonists (VKAs) need to be individually dosed. International guidelines recommend a target range of international normalised ratio (INR) of 2.0-3.0 for stroke prevention in atrial fibrillation (AF). We analysed the time in this therapeutic range (TTR) of VKA-treated patients with newly...

Full description

Bibliographic Details
Main Authors:	Sylvia Haas, Hugo Ten Cate, Gabriele Accetta, Pantep Angchaisuksiri, Jean-Pierre Bassand, A John Camm, Ramon Corbalan, Harald Darius, David A Fitzmaurice, Samuel Z Goldhaber, Shinya Goto, Barry Jacobson, Gloria Kayani, Lorenzo G Mantovani, Frank Misselwitz, Karen Pieper, Sebastian M Schellong, Janina Stepinska, Alexander G G Turpie, Martin van Eickels, Ajay K Kakkar, GARFIELD-AF Investigators
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5085020?pdf=render

Similar Items

Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation.
by: Jean-Pierre Bassand, et al.
Published: (2018-01-01)

Characteristics, treatment, and outcomes of newly diagnosed atrial fibrillation patients with heart failure: GARFIELD‐AF
by: Giuseppe Ambrosio, et al.
Published: (2021-04-01)

Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE
by: Walter Ageno, et al.
Published: (2021-02-01)

Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry.
by: Ajay K Kakkar, et al.
Published: (2013-01-01)

Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE
by: Carlos Jerjes-Sánchez, et al.
Published: (2021-01-01)

Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry
by: Shinya Goto, et al.
Published: (2019-02-01)

Do baseline characteristics and treatments account for geographical disparities in the outcomes of patients with newly diagnosed atrial fibrillation? The prospective GARFIELD-AF registry
by: Jonathan P Piccini, et al.
Published: (2022-01-01)

On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease
by: Sylvia Haas, et al.
Published: (2022-10-01)

Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registry
by: Ajay K Kakkar, et al.
Published: (2023-02-01)

Two-year outcomes of UK patients newly diagnosed with atrial fibrillation: findings from the prospective observational cohort study GARFIELD-AF
by: Apenteng, PN, et al.
Published: (2022)

Evolving antithrombotic treatment patterns in patients with newly diagnosed atrial fibrillation: UK findings from the GARFIELD-AF registry
by: Apenteng, P, et al.
Published: (2016)

Rhythm versus rate control in patients with newly diagnosed atrial fibrillation – Observations from the GARFIELD-AF registry
by: Marita Knudsen Pope, et al.
Published: (2023-12-01)

Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation – results from the GARFIELD-AF registry
by: Marita Knudsen Pope, et al.
Published: (2021-01-01)

Emulation of ARISTOTLE and ROCKET AF trials in real-world atrial fibrillation patients results in similar efficacy and safety as original landmark trials: insights from the GARFIELD-AF registry
by: Ralf E Harskamp, et al.
Published: (2025-01-01)

Atrial fibrillation outcomes in patients from Asia and non-Asia countries: insights from GARFIELD-AF
by: Karen Pieper, et al.
Published: (2025-02-01)

Impact of patient selection in clinical trials: application of ROCKET AF and ARISTOTLE criteria in GARFIELD-AF
by: Toon Wei Lim, et al.
Published: (2024-08-01)

33Patterns of antithrombotic therapy in relation to type of atrial fibrillation: insights from the UK cohort of the global GARFIELD registry.
by: Apenteng, P, et al.
Published: (2014)

Changes in anticoagulant prescription in Dutch patients with recent-onset atrial fibrillation: observations from the GARFIELD-AF registry
by: J. Seelig, et al.
Published: (2020-03-01)

GARFIELD-AF model for prediction of stroke and major bleeding in atrial fibrillation: a Danish nationwide validation study
by: Christian Torp-Pedersen, et al.
Published: (2019-11-01)

Reflections about Garfield’s algorithm
by: Laura Sinay, et al.
Published: (2019-12-01)

Speeding Up and Parallelizing the GARFIELD++
by: Sheharyar A., et al.
Published: (2018-01-01)

An international longitudinal registry of patients with atrial fibrillation at risk of stroke (GARFIELD): the UK protocol.
by: Apenteng, P, et al.
Published: (2013)

BERGIN AND GARFIELD'S HANDBOOK OF PSYCHOTHERAPY AND BEHAVIOR CHANGE /ergin and garfield's handbook of psychotherapy and behavior change /
by: Lambert, Michael J., editor 172833
Published: (2004)

Country and health expenditure are major predictors of withholding anticoagulation in atrial fibrillation patients at high risk of stroke
by: Bernard J Gersh, et al.
Published: (2023-11-01)

Bergin and Garfield's Handbook of Psychotherapy and Behavior Change /
by: Barkham, Michael, editor 374493, et al.
Published: (2020)

Vaccine‐induced immune thrombotic thrombocytopenia with ChAdOx1 nCoV‐19 is rare in Asia
by: Kochawan Boonyawat, et al.
Published: (2022-01-01)

XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation
by: Camm AJ, et al.
Published: (2014-07-01)

Garfield the movie / [digital video disc]
Published: (2004)

Reflexivity, transparency, and illusionism: Engaging Garfield
by: Zahavi, D
Published: (2020)

Study of the FTM Detector Performance with Garfield++
by: Yasser Maghrbi, et al.
Published: (2020-12-01)

In memoriam Eugene Garfield (1925-2017)
by: Evaristo Jiménez Contreras
Published: (2017-06-01)

Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial
by: Cools, F, et al.
Published: (2022)

Eugene Garfield—60 Years of Invention and Innovation
by: Alexander M. Grimwade
Published: (2018-03-01)

GTS – Garfield-based Triple-GEM Simulator
by: Farinelli Riccardo
Published: (2020-01-01)

Obituary: Dr. Eugene Garfield (1925-2017)
by: Allan Mwesiga
Published: (2017-03-01)

Critical appraisal of the role of recombinant activated factor VII in the treatment of hemophilia patients with inhibitors
by: Ampaiwan Chuansumrit, et al.
Published: (2010-03-01)

Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry
by: Apenteng, P, et al.
Published: (2018)

Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry
by: Apenteng, P, et al.
Published: (2018)

Garfield 2 [videorecording] : A tail of two kitties /
by: Davis Entertainment, et al.
Published: (2006)

The web of knowledge : a festchrift in honor of Eugene Garfield /
by: Cronin, Blaise, et al.
Published: (2000)